Top Markets
Coin of the day
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Rang în acțiuni #33273
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Preț acțiune
$5.47
Ultima sincronizare: 2026-08-14
Capitalizare de piață
$7.99M
Schimbare (1 zi)
6.21%
Schimbare (1 an)
7.47%
Țară
US
Tranzacționează CNS Pharmaceuticals, Inc. (CNSP)

Categorie

Istoric dividende pentru CNS Pharmaceuticals, Inc. (CNSP)
CNS Pharmaceuticals, Inc. (simbol acțiune: CNSP) a efectuat un total de 0 plăți de dividende.
Suma tuturor dividendelor (ajustată pentru split-uri de acțiuni) este: 0.00
Randamentul dividendului (TTM): 0
Plăți de dividende pentru CNS Pharmaceuticals, Inc. (CNSP) din 2026 până în 2026
Plăți anuale de dividende
An Dividend (ajustat pentru split de acțiuni) Schimbă
Nu sunt suficiente date pentru perioada selectată.
Lista tuturor plăților de dividende
An Dividend Schimbă
Nu sunt suficiente date pentru perioada selectată.
Dividende ale companiilor similare sau concurente
Companie Număr de plăți de dividende Țara
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
29.00%
BE